'Five in Five' Tips to Targeting IL-13 in Atopic Dermatitis
Released on
July 9, 2026
Earn up to
0.25 AMA PRA Category 1 Credit(s)™
Through short, focused bursts of information, gain five practical, practice-ready tips for optimizing IL-13 biologic therapy in atopic dermatitis, from individualizing treatment based on comorbidities, treatment history, and trial data to actionable dosing strategies that improve patient outcomes.
This activity is supported by an educational grant from Lilly.